Výsledky vyhledávání - "Andrew A. Bell"

Reference

Bell, Andrew (1753–1852) [Bell, Andrew]

Autor: Gordon, Peter

Publikováno v: The Oxford Companion to British History, 2 ed., 2015.

Externí odkaz: http://www.oxfordreference.com/view/10.1093/acref/9780199677832.001.0001/acref-9780199677832-e-422

Zobrazit plný text záznamu

Akademický článek

Craters of habit: Patterns of deformation in the western Galápagos

Autor: Eoin Reddin, Susanna Ebmeier, Marco Bagnardi, Andrew F. Bell, Pedro Espín Bedón

Publikováno v: Volcanica, Vol 7, Iss 1, Pp 181-227 (2024)

The western Galápagos islands of Fernandina and Isabela comprise six active volcanoes that have deformed since first observed by satellite radar in the early 1990s. We analyse new (2015–2022) displacement time series at Alcedo, Cerro Azul, Darwin

Externí odkaz: https://doaj.org/article/62febcc620314a0cb1605fd2bdbc84eb

Zobrazit plný text záznamu

Akademický článek

Comparative sanitation data from high-frequency phone surveys across 3 countries

Autor: Amy R. Lewis, Andrew R. Bell, Ana Casas, Beata Kupiec-Teahan, José Mendoza Sanchez, Simon Willcock, Fiona Anciano, Dani J. Barrington, Mmeli Dube, Paul Hutchings, Caroline Karani, Arturo Llaxacondor, Hellen López, Anna L. Mdee, Alesia D. Ofori, Joy N. Riungu, Kory C. Russel, Alison H. Parker

Publikováno v: Data in Brief, Vol 55, Iss , Pp 110635- (2024)

With less than half of the worldʼs urban population having safely managed sanitation due to the high cost and difficulty of building sewers and treatment plants, many rely on off-grid options like pit latrines and septic tanks, which are hard to emp

Externí odkaz: https://doaj.org/article/58c34a4f2ddd458eb97062efe4cb5466

Zobrazit plný text záznamu

Akademický článek

Assessing the Impact of PCSK9 and HMGCR Inhibition on Liver Function: Drug-Target Mendelian Randomization Analyses in Four AncestriesSummary

Autor: Daniel B. Rosoff, Andrew S. Bell, Josephin Wagner, Lucas A. Mavromatis, Ali Hamandi, Lauren Park, Jeesun Jung, Falk W. Lohoff

Publikováno v: Cellular and Molecular Gastroenterology and Hepatology, Vol 17, Iss 1, Pp 29-40 (2024)

Background & Aims: Observational studies have linked lipid-lowering drug targets pro-protein convertase subtilisin/kexin 9 (PCSK9) and HMG-CoA reductase (HMGCR) with adverse liver outcomes; however, liver disease incidence varies across diverse popul

Externí odkaz: https://doaj.org/article/0796deca2c944246820bcca9f91393cf

Zobrazit plný text záznamu